References
- Ciechanover, A., Orian, A. and Schwartz, A.L. (2000) “The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications”, Journal of Cellular Biochemistry Supplement 34, 40– 51.
- Giasson, B.I. and Lee, V.M. (2003) “Are ubiquitination pathways central to Parkinson’s disease?”, Cell 114, 1–8.
- Hartmann-Petersen, R., Seeger, M. and Gordon, C. (2003) “Transferring substrates to the 26S proteasome”, Trends in Biochemical Sciences 28, 26– 31.
- Hicke, L. and Dunn, R. (2003) “Regulation of membrane protein transport by ubiquitin and ubiquity-binding proteins”, Annual Review of Cell and Developmental Biology 19, 141– 172.
- Huang, H., Joazeiro, C.A., Bonfoco, E., Kamada, S., Leverson, J.D. and Hunter, T. (2000) “The inhibitor of apoptosis, cIAP2, functions as a ubiquitinprotein ligase and promotes in vitro monoubiquitination of caspases 3 and 7”, Journal of Biological Chemistry 275, 26661– 26664.
- Kugawa, F., Arae, K., Ueno, A. and Aoki, M. (1998) “Buprenor- phine hydrochloride induces apoptosis in NG108-15 nerve cells”, European Journal of Pharmacology 347, 105– 112.
- Kugawa, F., Ueno, A. and Aoki, M. (2000) “Apoptosis of NG108-15 cells induced by buprenorphine hydrochloride occurs via the caspase-3 pathway”, Biological & Pharmaceutical Bulletin 23, 930– 935.
- Kugawa, F., Matsumoto, K. and Aoki, M. (2004a) “Apoptosis-like cell death of human breast cancer cell line MCF-7 induced by buprenorphine hydrochloride”, Life Sciences 75, 287– 299.
- Kugawa, F., Nakamura, M., Ueno, A. and Aoki, M. (2004b). “Over-expression of Bcl-2 cannot suppress apoptosis via the mitochondria in buprenorphine hydrochloride-treated NG108-15 cells”, Biological Pharmaceutical Bulletin 27(9).
- Lee, S.W., Tomasetto, C. and Sager, R. (1991) “Positive selection of candidate tumor-suppressor genes by subtractive hybridization”, Proceedings of the National Academy of Sciences of the United States of America 88, 2825– 2829.
- Liang, P. and Pardee, A.B. (1992) “Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction”, Science 257, 967– 971.
- Martin, S.J. (2002) “Destabilizing influences in apoptosis: sowing the seeds of IAP destruction”, Cell 109, 793– 796.
- Nelson, P., Christian, C. and Nirenberg, M. (1976) “Synapse formation between clonal neuroblastoma £ glioma hybrid cells and striated muscle cells”, Proceedings of the National Academy of Sciences of the United States of America 73, 123–127. Orlowski, R.Z. (1999) “The role of the ubiquitin-proteasome pathway in apoptosis”, Cell Death and Differentiation 6, 303–313.
- Schena, M., Shalon, D., Heller, R., Chai, A., Brown, P.O. and Davis, R.W. (1996) “Parallel human genome analysis: microarray- based expression monitoring of 1000 genes”, Proceedings of the National Academy of Sciences of the United States of America 93, 10614– 10619.
- Sokolov, B.P. and Prockop, D.J. (1994) “A rapid and simple PCR-based method for isolation of cDNAs from differentially expressed genes”, Nucleic Acids Research 22, 4009– 4015.
- Voges, D., Zwickl, P. and Baumeister, W. (1999) “The 26S proteasome: a molecular machine designed for controlled proteolysis”, Annual Review of Biochemistry 68, 1015– 1068.
- Wang, T. (2003) “The 26S proteasome system in the signaling pathways of TGF-b superfamily”, Frontiers in Biosciences 8, d1109– d1127.
- Welsh, J., Chada, K., Dalal, S.S., Cheng, R., Ralph, D. and McClelland, M. (1992) “Arbitrarily primed PCR fingerprint- ing of RNA”, Nucleic Acids Research 20, 4965– 4970.
- Yang, Y. and Yu, X. (2003) “Regulation of apoptosis: the ubiquitous way”, The FASEB Journal 17, 790– 799.